To our best knowledge, this is the first prospective study that longitudinally examined cachexia-related circulating cytokines, both at baseline and during treatment, and assessed their role in predicting the clinical outcomes of lung cancer patients treated with PD-1/PD-L1 blockade. The gene discussed is CD274; the disease is lung cancer.